lu codes
Source: ODB Formulary/CDI, edition 43 (effective 2026-04-28). Checked weekly for updates. Unofficial search tool.
/
2 drugs, 2 codes
FESOTERODINE FUMARATE, MIRABEGRON, DARIFENACIN, SOLIFENACIN SUCCINATE, TOLTERODINE L-TARTRATE, TROSPIUM CHLORIDE Toviaz, Sandoz Fesoterodine Fumarate, Myrbetriq, Enablex, Apo-Darifenacin, Jamp Darifenacin +24 more
For patients with urinary frequency, urgency or urge incontinence who have:
Indefinite
Failed to respond to behavioral techniques AND an adequate trial of oxybutynin with gradual dose escalation has shown to be either ineffective or resulted in unacceptable side effects.
NOTE: If after a trial of 2 weeks patients continue to experience similar side effects and no greater efficacy than oxybutynin, continued therapy with this more costly agent should be reassessed.
Antimuscarinic agents should be used with caution in the elderly due to potentially serious adverse effects (e.g. confusion, psychosis, acute urinary retention, constipation). Antimuscarinic agents should be avoided in older adults with pre-existing cognitive impairment (e.g. dementia) and those who are already using other drugs with significant anticholinergic effects (e.g. tricyclic antidepressants) in order to avoid a high overall anticholinergic drug burden.
PROPIVERINE HYDROCHLORIDE Mictoryl Pediatric
For the symptomatic treatment of urinary incontinence and/or increased urinary frequency and urgency in pediatric patients with overactive bladder.
1 year
genitourinary smooth muscle relaxants antimuscarinics
No matching LU codes found.